NRx Pharmaceuticals, Inc. (NRXP) NASDAQ
4.62
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.62
+0(+0.00%)
Currency In USD
| Market Cap | 58M |
| Enterprise Value | 50.83M |
| P/E Ratio | -6.09 |
| PEG Ratio | -0.17 |
| Price/Sales Ratio | 34.83 |
| Price/Book Ratio | -10.81 |
| Enterprise/Revenue | 32.31 |
| Enterprise/EBITDA | -2.41 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -10.7 |
| Operating Margin | -7.5 |
| Return On Assets | -2.06 |
| Return On Equity | 1.08 |
| Revenue | 1.23M |
| Revenue/Share | 0.07 |
| Gross Profit | 720,000 |
| EBITDA | -27.81M |
| Net Income | -28.62M |
| Diluted EPS | -1.34 |
| Total Cash | 6.71M |
| Total Cash/Share | 0.21 |
| Total Debt | 934,000 |
| Total Debt/Equity | -0.07 |
| Current Ratio | 0.29 |
| Book Value Per Share | -0.43 |
| 52-Week Change | 69.85 |
| 52-Week High | 5.06 |
| 52-Week Low | 1.62 |
| Moving Average 50 Days | 2.91 |
| Moving Average 200 Days | 2.58 |
| Average Volume | 1.13M |
| Shares Outstanding | 17.29M |
| % Held by Institutions | 28.79 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | April 02, 2024 |